Introduction {#sec1-1}
============

Coagulase-negative staphylococci (CoNS) have been recognized as an important agent of human infection since the past five decades.\[[@ref1]\] Currently, there are 38 species of CoNS isolated from various human infections.\[[@ref2]\] The important among them are *Staphylococcus saprophyticus*, *Staphylococcus epidermidis*, *Staphylococcus haemolyticus*, *Staphylococcus lugdunensis*, *Staphylococcus hominis*, *Staphylococcus capitis*, *Staphylococcus warneri*, and *Staphylococcus xylosus*.\[[@ref3]\] Earlier CoNS were taken as insignificant contaminant; now, they are regarded as major cause of nosocomial bloodstream infections, urinary tract infections, skin and soft-tissue infections, and various indwelling device-related and prosthetic implants infections.\[[@ref4]\] The significant change in the patients' profile, that is, increased number of premature newborns, elderly patients, chronically ill patients, and immunocompromised patients along with greater use of indwelling or implanted foreign body has made CoNS a predominant nosocomial pathogen. Colonization of skin and mucous membrane of the inpatient by multidrug resistant CoNS strain and its transmission by hands of health-care workers is critical step in the making CoNS a successful nosocomial pathogen.\[[@ref5]\]

In addition, there is increasing antimicrobial drug resistance in CoNS limiting our therapeutic options. Human and animal origin CoNS harbor large reservoir of mobile genetic elements, which led to resistance to β-lactams, aminoglycosides, quinolones, macrolides, and tetracyclines. Resistance to β-lactams, that is, MRCoNS (methicillin-resistant CoNS) are determined by the presence of *mecA* gene carried on a mobile genetic element, that is, staphylococcal chromosomal cassette *mec*.\[[@ref4]\]

The macrolides, lincosamides, and streptogramin B (MLS~B~) group of antimicrobial agents are frequently used as a drug of choice in the treatment of skin and soft-tissue infection due to CoNS and as a substitute in penicillin allergic patients. The most common mechanism of resistance to MLS~B~ is due to *erm* gene which causes methylation of 23S rRNA leading to reduced binding of MLS~B~ agents to ribosomes.\[[@ref6]\] This *erm* gene encodes enzyme methylase either constitutively (cMLS~B~) or is inducible by certain substance (iMLS~B~).\[[@ref7]\] These MLS~B~i strains show *in vitro* resistance to erythromycin while appearing susceptible to clindamycin, leading to failure to identify the resistance and clinical failure to clindamycin. Since erythromycin is an effective inducer of iMLS~B~ resistance, therefore, using erythromycin disc in close proximity to clindamycin disc (D-test) helps in detecting this type of resistance in CoNS. Failure to identify iMLS~B~ resistance may lead to clinical failure of clindamycin therapy. On the contrary, categorizing all erythromycin-resistant CoNS as clindamycin resistant will prevent the use of clindamycin in infections caused by truly clindamycin sensitive isolates.\[[@ref5]\]

There are very few studies demonstrating the epidemiology and resistance profile of CoNS.\[[@ref8]\] Thus, the aim of our study is to identify the various species of CoNS from clinical samples of blood, pus, sterile body fluids, and wound swab study their antibiotic susceptibility pattern and detect iMLS~B~ resistance using D-test for the isolated organisms.

Materials and Methods {#sec1-2}
=====================

Study design and setting {#sec2-1}
------------------------

The present study was conducted in the Department of Microbiology, Government Medical College and Hospital, Chandigarh, for 6 months from January 15, 2017, to July 15, 2017. A total of 120 consecutive, clinically significant strains of CoNS isolated in the Department of Microbiology, Government Medical College Hospital, Chandigarh, from various clinical samples were evaluated. These samples were blood wound swab, drain fluid, tracheal aspirate, peritoneal fluid, pleural fluid, and high vaginal swab.

Inclusion criteria {#sec2-2}
------------------

CoNS was considered the significant cause of bacteremia when

The same CoNS strain was isolated two or more times from blood culture sample within 5 days\[[@ref5]\]In case only one blood culture sample yielded growth of CoNS then at least two clinical parameter was taken into consideration -- Body temperature \>38°C or \<36°C, TLC \>12,000/μL or \<2000/μL, or systolic blood pressure \<90 mmHg.

These findings were taken by clinical evaluation of the patient if only one blood culture bottle grew CoNS isolate. In case of sites such as drain fluid, tracheal aspirate, and high vaginal swabs a repeat culture showing the same growth was taken as significant. Therefore, only clinical significant isolates were processed.

Strain identification {#sec2-3}
---------------------

CoNS was identified by characteristic growth on blood agar, MacConkey agar, Gram staining, and various biochemical tests such as -- free and bound coagulase. The following biochemical tests were performed for CoNS-PYR broth hydrolysis, novobiocin resistance, polymyxin B sensitivity, ornithine decarboxylase, and Voges Proskauer reactions.\[[@ref2][@ref3]\] The isolates were then confirmed using matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS, Bruker Daltonics, Germany).

Antibiotics susceptibility {#sec2-4}
--------------------------

Antibiotic susceptibility of the isolates is done by Kirby-Bauer\'s disc diffusion method following CLSI 2017 guidelines. The following antibiotics were used -- penicillin (10 μg), oxacillin (30 μg), ciprofloxacin (5 μg), erythromycin (15 μg), clindamycin (2 μg), doxycycline (30 μg), gentamicin (10 μg), cotrimoxazole (1.25/23.75 μg), linezolid (30 μg), and teicoplanin (30 μg).\[[@ref9]\]

In addition, the degree of resistance was defined as being high if resistance was \>60%, moderate if resistance was between 60% and 30% and low resistance when the isolates showed resistance \<30%.

For vancomycin-resistant CoNS, vancomycin screen agar (MHA with 6 μg/ml of vancomycin) was used.

D-TEST: All erythromycin resistant and clindamycin sensitive Staphylococcus strains were further tested by D-test. The standard recommendations for inoculum preparation and inoculation were followed on Mueller-Hinton agar. The erythromycin disc was placed at a distance of 15 mm (edge-to-edge) from clindamycin disc. After 18--24 h incubation at 37°C, appearance of clindamycin zone closest to erythromycin disc was noted.\[[@ref7]\]

Reporting {#sec2-5}
---------

Growth up to clindamycin and erythromycin discs indicates resistance to both erythromycin and clindamycin (cMLS~B~ phenotype)Demonstration of flattened CLI zone between erythromycin and clindamycin disc shows inducible clindamycin resistance, (iMLS~B~ phenotype)No flattening of clindamycin zone-negative for inducible clindamycin resistance (MS phenotype), that is, resistant to erythromycin but susceptible to clindamycin.\[[@ref6]\]

Results {#sec1-3}
=======

Out of the total 120 samples isolated, 68 strains of CoNS were isolated from blood, and 52 strains were from pus samples. The most common CoNS in our hospital setting was *S. epidermidis* (56.67%), *then S. haemolyticus* (21.67%) *S. lugdunensis* (11.67%), *Staphylococcus caprae* (5%), *Staphylococcus cohnii* (3.33%), and finally *Staphylococcus vitulinus* (1.67%) \[[Table 1](#T1){ref-type="table"}\]. There was 100% correlation between strains identified by biochemical reactions and MALDI-TOF MS

###### 

Number and percentage of each coagulase negative staphylococci species isolated

![](JLP-10-414-g001)

*S. epidermidis* showed high degree of resistance to penicillin (97%), oxacillin (64.7%), moderate resistance toward ciprofloxacin (58.8%), cotrimoxazole (47%), and low degree of resistance to doxycycline (23.5%), gentamicin (26.5%), and no resistance to linezolid, teicoplanin, and vancomycin \[[Table 2](#T2){ref-type="table"}\].

###### 

Resistance percentage of various coagulase negative staphylococci species isolated

![](JLP-10-414-g002)

Similarly, *S. haemolyticus* showed a high degree of resistance toward penicillin (96.2%), ciprofloxacin (72.3%), gentamicin (72%), moderate degree of resistance toward cotrimoxazole (46.2%), oxacillin (34.6%), and doxycycline (30.7%). No resistance to linezolid, teicoplanin, and vancomycin \[[Table 2](#T2){ref-type="table"}\].

*S. lugdunensis*, *S. caprae*, and *S. cohnii* showed a high level of resistance toward penicillin (85%--100%), ciprofloxacin (50%--100%), and oxacillin (50%--66%). A lower degree of resistance was seen to gentamicin (25%--33%), cotrimoxazole (33%--50%), doxycycline (50%--14%), and no resistance to linezolid, teicoplanin, and vancomycin. Both the strains of *S. vitulinus* showed 100% resistance to penicillin, erythromycin, and gentamicin.

On PubMed search for Indian study for antibiotics resistance pattern of different CONS species in the last 10 years.

Among the 120 CoNS isolates, 43 isolates (35.8%) showed iMLS phenotype, 25 isolates (20.8%) showed cMLS phenotype, 16 isolates (13.3%) showed MS phenotype, and 36 isolates (29.9%) were sensitive to both clindamycin and erythromycin.

Out of 43 isolates showing of iMLS phenotype (D-test positive), maximum number was for *S. epidermidis* (62.8%) and *S. haemolyticus* (20.9%). Four strains of *S. lugdunensis*, two of *S. cohnii*, and one strain of *S. caprae* were D-test positive. No *S. vitulinus* showed inducible clindamycin resistance.

Discussion {#sec1-4}
==========

The main problem in reporting of CoNS isolate from any clinical sample is to rule out colonization or contamination and report it as a true pathogen. In circumstances where false-positive CoNS reports are given, it leads to unnecessary treatment and cost and further increasing antimicrobial resistance. Isolation of CoNS strain in pure culture and repeated isolation of the same strain are useful in predicting true infections.\[[@ref10]\] In our study, only significant CoNS were included in the study.

In our study, *S. epidermidis* (56.6%) was the most common species followed by *S. haemolyticus* (21.6%) and *S. lugdunensis* (11.6%). Similar results have been shown by Usha MG *et al*., who studied the epidemiology from blood, pus, and urine isolates and showed that *S. epidermidis* was the most common isolate followed by *S. haemolyticus and S. lugdunensis*.\[[@ref11]\] In addition, Sheikh and Asangi *et al*. in their respective study showed that *S. epidermidis* and *S. haemolyticus* are the two most common isolates from the clinical samples from their respective hospital setting.\[[@ref12][@ref13]\] In contrast, another study from northern India by Singh *et al*. showed *S. haemolyticus* (47.8%) as the most common isolate followed by *S. epidermidis* (33.4%).\[[@ref4]\] This reveals that there exist variation in different species geographically. This may be due to variability in colonization by CoNS of skin and mucous membrane in diverse hospital setting owing to differences in antimicrobial pressure.

*S. epidermidis* and *S. haemolyticus* are frequent colonize moist body surfaces such as axillae, inguinal, and perineal area. These natural colonizers of skin have adapted expertly to become nosocomial pathogens because they exhibit of resistance to antibiotics and antiseptics as well as their capacity to produce biofilm.\[[@ref5]\]

On PubMed search for Indian study on antibiotics resistance pattern of different CoNS species during the last 10 years, two studies were found -- Asangi *et al*. (2011) and Singh S *et al*.\[[@ref4][@ref13]\] Both the authors showed similar resistance high resistance to penicillin for *S. epidermidis*, *S. saprophyticus*, and *S. haemolyticus*; similar to our study. In contrast, *S. lugdunensis* showed 100% resistance to penicillin by Asangi *et al*. whereas all the isolates of *S. lugdunensis* were sensitive to penicillin in the study by Singh *et al*. \[[Table 3](#T3){ref-type="table"}\].

###### 

Comparison of resistance percentage of coagulase negative staphylococci isolates from two Indian studies

![](JLP-10-414-g003)

The prevalence of MRCoNS in our study ranged from 50% to 68.67%. The highest methicillin resistance was in *S. caprae* (66.67%), *S. epidermidis* (64.71%), *S. lugdunensis* (57.1%), and *S. haemolyticus* (34.6%). In the study by Asangi *et al*., 67.7% of CoNS were MRCoNS. This varied from *S. haemolyticus* and *S. lugdunensis* being 100% methicillin resistant to being 69.2% and *S. epidermidis* being 49% methicillin resistant.\[[@ref13]\] Likewise, Singh *et al*. reported 100% of all *S. haemolyticus* strains, 81% *S. epidermidis*, 72% *S. warneri*, and 25% *S. xylosus* as being MRCoNS. In contrast, none of the S. *lugdunensis* were methicillin resistant in the study by Singh *et al*.\[[@ref14]\] Similar high prevalence of MRCoNS have been reported by other authors such as Jain (48.2%) *et al*., Singh *et al*. (57.6%), and Pereira *et al*. (60%).\[[@ref4]\] The high prevalence of MRCoNS not only decreases the treatment options and also assists in transfer of the resistance elements to other staphylococcal strains present in the hospital settings. The presence of methicillin resistance in CoNS has the potential or the ability to transfer resistance mechanisms to other virulent pathogens such as *Staphylococcus aureus* present on the skin and environment.

In addition, *S. epidermidis* and *S. haemolyticus* showed high resistance was seen to other non β-lactam antimicrobial agents -- ciprofloxacin (58%--72%), gentamicin (26%--72%), and cotrimoxazole (46%--47%). Singh *et al*. showed similar results in their study. The resistance to ciprofloxacin varied from 84% in *S. hemolyticus*, 48% in *S. saprophyticus*, and 45% in *S. epidermidis*. Similar for gentamicin -- 84% in *S. hemolyticus*, 42% in *S. saprophyticus*, and 27% in *S. epidermidis*.\[[@ref14]\] Singh *et al*. showed that high resistance to ciprofloxacin, cotrimoxazole, rifampicin, and amikacin. Nearly 50% of *S. lugdunensis*, *S. caprae*, *S. cohnii*, and S. *vitulinus* isolates were MRCoNS and showed high resistance to ciprofloxacin and cotrimoxazole.\[[@ref4]\] All CoNS isolates from our hospital setting were susceptible to linezolid, teicoplanin, and vancomycin. Linezolid was sensitive to all species of CoNS in the study by Asangi *et al*. and Singh *et al*.\[[@ref13][@ref14]\] These are reserve drugs and should be used judicially.

Clindamycin is an excellent drug for Staphylococcal skin and soft-tissue infections and as an alternative in penicillin-allergic patient. Moreover, due to good oral bioavailability, it a preferred option for outpatient therapy and changeover after intravenous antibiotics. The differentiation of *erm*-mediated iMLS~B~ phenotype isolates from isolates with MS phenotype resistance is critical issue for any clinical microbiology laboratory, because of the therapeutic implications of using clindamycin to treat a patient with an inducible clindamycin-resistant *S. aureus* isolate. As iMLS~B~ phenotype is not recognized using standard susceptibility test methods; hence, D-test has to be done separately. In our institute, out the 120 CoNS isolates 20.8% showed cMLS phenotype, 35.8% showed iMLS phenotype, and 13.3% showed MS phenotype. Pal N *et al*. in a similar study found 46.97% of Staphylococcal isolates to be having cMLS phenotype, 23.48% were iMLS phenotype, and 29.5% showed MS phenotype.\[[@ref7]\] Furthermore, similar findings are reported by Fiebelkorn *et al*. who found 30.5% of CoNS to be having inducible clindamycin resistance.\[[@ref6]\]

Conclusion {#sec1-5}
==========

CoNS should be regarded as pathogen of significance and not as contaminant only. Various species such as *S. epidermidis*, *S. haemolyticus*, and *S. lugdunensis* are causing infections these days. MR CoNS prevalence is also increasing and was in the range of 50%--68.67% for various species in this study. The other antibiotics to which resistance was noted where penicillin (96.5%), ciprofloxacin (57.15), and cotrimoxazole (44.9%). 100% susceptibility was seen towards vancomycin, teicoplanin, and linezolid. Still these drugs should be used as reserve drugs. To prevent CoNS infections, hospital infection control measures should be strengthened, and staff should be instructed to follow hand hygiene practice. Speciation of CoNS and its antibiotic susceptibility pattern will guide the clinicians in establishing their role as significant pathogens and initiate proper antimicrobial therapy based on the susceptibility pattern.
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